Overview
Status
Active
Registry date
2025-05-21
Share capital
4,350.00 PLN
Registered address
ul. Tarczyńska 5/9/36, 02-025 Warszawa, Poland
Electronic delivery address
AE:PL-96528-78488-AWDVI-28
Financials
Filing timeliness
The financial statement for 2025 was filed on time.
- 202510/07/2026
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
- Manufacture of medical and dental instruments and supplies (32.5)
Authorized Representatives
Jan Kruś – President of the Management Board
Julita Kuczyńska – Vice President of the Management Board
Paweł Kruś – Vice President of the Management Board
Manner of representation
In the case of a multi-member management board, two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorised to represent the company.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
FAQ
Last updated: 2026-07-16